ID   RASF5_RAT               Reviewed;         413 AA.
AC   O35141;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   29-MAY-2024, entry version 139.
DE   RecName: Full=Ras association domain-containing protein 5;
DE   AltName: Full=Maxp1;
DE   AltName: Full=New ras effector 1;
GN   Name=Rassf5; Synonyms=Nore1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Slepnev V.I., De Camilli P.V.;
RT   "Maxp1, protein interacting with guanine nucleotide exchange factor Mss4.";
RL   Submitted (MAY-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   INTERACTION WITH HRAS.
RX   PubMed=12676952; DOI=10.1074/jbc.m211019200;
RA   Vos M.D., Martinez A., Ellis C.A., Vallecorsa T., Clark G.J.;
RT   "The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor
RT   suppressor in the lung.";
RL   J. Biol. Chem. 278:21938-21943(2003).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Potential tumor suppressor. Seems to be involved in
CC       lymphocyte adhesion by linking RAP1A activation upon T-cell receptor or
CC       chemokine stimulation to integrin activation. Stimulates lymphocyte
CC       polarization and the patch-like distribution of ITGAL/LFA-1, resulting
CC       in an enhanced adhesion to ICAM1. Together with RAP1A may participate
CC       in regulation of microtubule growth. The association with activated
CC       RAP1A is required for directional movement of endothelial cells during
CC       wound healing. May be involved in regulation of Ras apoptotic function.
CC       The RASSF5-STK4/MST1 complex may mediate HRAS and KRAS induced
CC       apoptosis (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts directly with activated HRAS; a RASSF5-STK4/MST1
CC       complex probably associates with activated HRAS. Interacts with KRAS.
CC       Probably interacts with Ras-like GTPases RRAS, MRAS, RAP1B, RAP2A and
CC       RALA (By similarity). Interacts with RRAS2 (By similarity). Can self-
CC       associate. Interacts with RSSF1 isoform A. The RSSF1 isoform A-RSSF5
CC       heterodimer probably mediates the association of RSSF1 with HRAS (By
CC       similarity). Isoform 2 interacts with activated RAP1A and ITGAL/LFA-1.
CC       Binds STK4/MST1, inhibiting STK4/MST1 autoactivation (By similarity).
CC       {ECO:0000250|UniProtKB:Q5EBH1, ECO:0000250|UniProtKB:Q8WWW0}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}. Note=Mainly located in the perinuclear region of
CC       unstimulated primary T-cells; upon stimulation translocates to the
CC       leading edge and colocalizes with ITGAL/LFA-1 in the peripheral zone of
CC       the immunological synapse. Localized to growing microtubules in
CC       vascular endothelial cells and is dissociated from microtubules by
CC       activated RAP1A (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF002251; AAB71821.1; -; mRNA.
DR   RefSeq; NP_062238.1; NM_019365.3.
DR   AlphaFoldDB; O35141; -.
DR   SMR; O35141; -.
DR   STRING; 10116.ENSRNOP00000008055; -.
DR   iPTMnet; O35141; -.
DR   PhosphoSitePlus; O35141; -.
DR   PaxDb; 10116-ENSRNOP00000008055; -.
DR   Ensembl; ENSRNOT00000008055.6; ENSRNOP00000008055.3; ENSRNOG00000005342.8.
DR   Ensembl; ENSRNOT00055034876; ENSRNOP00055028288; ENSRNOG00055020392.
DR   Ensembl; ENSRNOT00060025576; ENSRNOP00060020403; ENSRNOG00060014938.
DR   Ensembl; ENSRNOT00065036003; ENSRNOP00065029038; ENSRNOG00065021167.
DR   GeneID; 54355; -.
DR   KEGG; rno:54355; -.
DR   UCSC; RGD:621694; rat.
DR   AGR; RGD:621694; -.
DR   CTD; 83593; -.
DR   RGD; 621694; Rassf5.
DR   eggNOG; KOG4239; Eukaryota.
DR   GeneTree; ENSGT00940000159288; -.
DR   HOGENOM; CLU_045544_0_0_1; -.
DR   InParanoid; O35141; -.
DR   OrthoDB; 4260488at2759; -.
DR   PhylomeDB; O35141; -.
DR   TreeFam; TF319243; -.
DR   PRO; PR:O35141; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000005342; Expressed in spleen and 20 other cell types or tissues.
DR   ExpressionAtlas; O35141; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0046651; P:lymphocyte proliferation; ISO:RGD.
DR   GO; GO:0050672; P:negative regulation of lymphocyte proliferation; ISO:RGD.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:1900180; P:regulation of protein localization to nucleus; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd20886; C1_RASSF5; 1.
DR   CDD; cd17220; RA_RASSF5; 1.
DR   CDD; cd21892; SARAH_RASSF5; 1.
DR   Gene3D; 1.20.5.110; -; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000159; RA_dom.
DR   InterPro; IPR033614; RASSF1-6.
DR   InterPro; IPR033623; RASSF5_RA.
DR   InterPro; IPR011524; SARAH_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR22738:SF9; RAS ASSOCIATION DOMAIN-CONTAINING PROTEIN 5; 1.
DR   PANTHER; PTHR22738; RASSF; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF16517; Nore1-SARAH; 1.
DR   Pfam; PF00788; RA; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00314; RA; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   PROSITE; PS50200; RA; 1.
DR   PROSITE; PS50951; SARAH; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Cytoplasm; Cytoskeleton; Metal-binding; Microtubule;
KW   Phosphoprotein; Reference proteome; Tumor suppressor; Zinc; Zinc-finger.
FT   CHAIN           1..413
FT                   /note="Ras association domain-containing protein 5"
FT                   /id="PRO_0000240403"
FT   DOMAIN          265..359
FT                   /note="Ras-associating"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00166"
FT   DOMAIN          361..408
FT                   /note="SARAH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00310"
FT   ZN_FING         117..165
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          1..105
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        57..78
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        80..94
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         177
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         274
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WWW0"
FT   MOD_RES         347
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WWW0"
SQ   SEQUENCE   413 AA;  46680 MW;  4A44E5830D9F094D CRC64;
     MASPAIGQRP YPLLLDPEPP RYLQSLGGTE PPPPARPRRC IPTALISASG ASEGRGSRRN
     ARGDPEPTPR DCRHARPVRP GLQQRLRRRP GSHRPRDVRS IFEQPQDPRV LAERGEGHRF
     AELALRGGPG WCDLCGREVL RQALRCANCK FTCHPECRSL IQLDCRQKEG PALDRQSPES
     TLTPTFNKNV CKAVEETQHP PTIQEIKQKI DSYNSREKHC LGMKLSEDGT YTGFIKVHLK
     LRRPVTVPAG IRPQSIYDAI KEVNPAATTD KRTSFYLPLD AIKQLHISSS TTVSEVIQGL
     LKKFMVVDNP QKFALFKRIH KDGQVLFQKL SIADCPLYLR LLAGPDTDVL SFVLKENETG
     DVEWDAFSIP ELQNFLTILE KEEQDKIHQL QKKYNKFRQK LEEALRESQG KPG
//
